Anti-KCNV2 antibodies are used in the immunodetection of the protein potassium voltage-gated channel modifier subfamily V member 2. In humans, the canonical protein has a reported length of 545 amino acid residues and a mass of 62.5 kDa. Its subcellular localization is in the cell membrane. It is notably expressed in the lung, liver, kidney, pancreas, spleen, thymus, prostate, testis, ovary and colon. A member of the Potassium channel protein family, KCNV2 is known to be involved with potassium ion transport and protein oligomerization. Post-translational modifications have been described, including glycosylation. The KCNV2 gene has been associated with the disease, Cone dystrophy retinal. Synonyms for this target antigen include potassium channel, subfamily V, member 2, potassium channel, voltage gated modifier subfamily V, member 2, voltage-gated potassium channel subunit Kv8.2, and potassium voltage-gated channel subfamily V member 2. KCNV2 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Western Blot is the most common application for the KCNV2 antibodies listed below. ELISA and Immunohistochemistry are also common applications.